Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole Based on Prior Endocrine Therapy in Patients With PIK3CA Mutation With Advanced Breast Cancer Who Have Progressed on or After Prior Treatments

  • STATUS
    Recruiting
  • End date
    Jul 15, 2022
  • participants needed
    390
  • sponsor
    Novartis Pharmaceuticals
Updated on 5 May 2021
Investigator
Novartis Pharmaceuticals
Primary Contact
Novartis Investigative Site (7.4 mi away) Contact
+120 other location
measurable disease
endocrine therapy
hormone therapy
advanced breast cancer
HER2
PIK3CA
cancer treatment
gonadotropin releasing hormone
tamoxifen
estradiol
fulvestrant
erbb2
letrozole
immunostimulant
mammogram

Summary

Study assessing the efficacy and safety of alpelisib plus fulvestrant or letrozole, based on prior endocrine therapy, in patients with PIK3CA mutation with advanced breast cancer who have progressed on or after prior treatments

Details
Condition Breast Cancer, Breast Cancer Diagnosis, breast carcinoma, cancer, breast
Treatment Letrozole, Goserelin, fulvestrant, Leuprolide, Alpelisib
Clinical Study IdentifierNCT03056755
SponsorNovartis Pharmaceuticals
Last Modified on5 May 2021

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note